Cargando…
Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
Duchenne Muscular Dystrophy (DMD) is a debilitating muscle disorder that condemns patients to year-long dependency on glucocorticoids. Chronic glucocorticoid use elicits many unfavourable side-effects without offering satisfying clinical improvement, thus, the search for alternative treatments to al...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455265/ https://www.ncbi.nlm.nih.gov/pubmed/36076964 http://dx.doi.org/10.3390/ijms23179567 |
_version_ | 1784785544472952832 |
---|---|
author | Merckx, Caroline Zschüntzsch, Jana Meyer, Stefanie Raedt, Robrecht Verschuere, Hanne Schmidt, Jens De Paepe, Boel De Bleecker, Jan L. |
author_facet | Merckx, Caroline Zschüntzsch, Jana Meyer, Stefanie Raedt, Robrecht Verschuere, Hanne Schmidt, Jens De Paepe, Boel De Bleecker, Jan L. |
author_sort | Merckx, Caroline |
collection | PubMed |
description | Duchenne Muscular Dystrophy (DMD) is a debilitating muscle disorder that condemns patients to year-long dependency on glucocorticoids. Chronic glucocorticoid use elicits many unfavourable side-effects without offering satisfying clinical improvement, thus, the search for alternative treatments to alleviate muscle inflammation persists. Taurine, an osmolyte with anti-inflammatory effects, mitigated pathological features in the mdx mouse model for DMD but interfered with murine development. In this study, ectoine is evaluated as an alternative for taurine in vitro in CCL-136 cells and in vivo in the mdx mouse. Pre-treating CCL-136 cells with 0.1 mM taurine and 0.1 mM ectoine prior to exposure with 300 U/mL IFN-γ and 20 ng/mL IL-1β partially attenuated cell death, whilst 100 mM taurine reduced MHC-I protein levels. In vivo, histopathological features of the tibialis anterior in mdx mice were mitigated by ectoine, but not by taurine. Osmolyte treatment significantly reduced mRNA levels of inflammatory disease biomarkers, respectively, CCL2 and SPP1 in ectoine-treated mdx mice, and CCL2, HSPA1A, TNF-α and IL-1β in taurine-treated mdx mice. Functional performance was not improved by osmolyte treatment. Furthermore, ectoine-treated mdx mice exhibited reduced body weight. Our results confirmed beneficial effects of taurine in mdx mice and, for the first time, demonstrated similar and differential effects of ectoine. |
format | Online Article Text |
id | pubmed-9455265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94552652022-09-09 Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse Merckx, Caroline Zschüntzsch, Jana Meyer, Stefanie Raedt, Robrecht Verschuere, Hanne Schmidt, Jens De Paepe, Boel De Bleecker, Jan L. Int J Mol Sci Article Duchenne Muscular Dystrophy (DMD) is a debilitating muscle disorder that condemns patients to year-long dependency on glucocorticoids. Chronic glucocorticoid use elicits many unfavourable side-effects without offering satisfying clinical improvement, thus, the search for alternative treatments to alleviate muscle inflammation persists. Taurine, an osmolyte with anti-inflammatory effects, mitigated pathological features in the mdx mouse model for DMD but interfered with murine development. In this study, ectoine is evaluated as an alternative for taurine in vitro in CCL-136 cells and in vivo in the mdx mouse. Pre-treating CCL-136 cells with 0.1 mM taurine and 0.1 mM ectoine prior to exposure with 300 U/mL IFN-γ and 20 ng/mL IL-1β partially attenuated cell death, whilst 100 mM taurine reduced MHC-I protein levels. In vivo, histopathological features of the tibialis anterior in mdx mice were mitigated by ectoine, but not by taurine. Osmolyte treatment significantly reduced mRNA levels of inflammatory disease biomarkers, respectively, CCL2 and SPP1 in ectoine-treated mdx mice, and CCL2, HSPA1A, TNF-α and IL-1β in taurine-treated mdx mice. Functional performance was not improved by osmolyte treatment. Furthermore, ectoine-treated mdx mice exhibited reduced body weight. Our results confirmed beneficial effects of taurine in mdx mice and, for the first time, demonstrated similar and differential effects of ectoine. MDPI 2022-08-24 /pmc/articles/PMC9455265/ /pubmed/36076964 http://dx.doi.org/10.3390/ijms23179567 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Merckx, Caroline Zschüntzsch, Jana Meyer, Stefanie Raedt, Robrecht Verschuere, Hanne Schmidt, Jens De Paepe, Boel De Bleecker, Jan L. Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title | Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title_full | Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title_fullStr | Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title_full_unstemmed | Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title_short | Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse |
title_sort | exploring the therapeutic potential of ectoine in duchenne muscular dystrophy: comparison with taurine, a supplement with known beneficial effects in the mdx mouse |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455265/ https://www.ncbi.nlm.nih.gov/pubmed/36076964 http://dx.doi.org/10.3390/ijms23179567 |
work_keys_str_mv | AT merckxcaroline exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT zschuntzschjana exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT meyerstefanie exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT raedtrobrecht exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT verschuerehanne exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT schmidtjens exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT depaepeboel exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse AT debleeckerjanl exploringthetherapeuticpotentialofectoineinduchennemusculardystrophycomparisonwithtaurineasupplementwithknownbeneficialeffectsinthemdxmouse |